VEGFA and age-related macular degeneration: Previous studies with P131 in early-stage exudative AMD indicated that differences between central and peripheral macula were either indicative of response to initial treatment with anti-VEGF [44] or were predictive of the need for anti-VEGF treatment [30] on prn management over 15 months.